New pill tested for hard-to-treat cancers
NCT ID NCT06568614
First seen Feb 05, 2026 · Last updated May 24, 2026 · Updated 15 times
Summary
This early-stage study tested a new pill called BG-89894 in 29 adults with advanced solid tumors that have a specific genetic change (MTAP deletion). The main goals were to check the drug's safety, find the best dose, and see if it shows any signs of shrinking tumors. The study was stopped early, so results are limited.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ADVANCED OR METASTATIC MTAP-DELETED SOLID TUMORS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Beijing Cancer Hospital
Beijing, Beijing Municipality, 100142, China
-
Beijing Tsinghua Changgung Hospital
Beijing, Beijing Municipality, 102218, China
-
Blacktown Cancer and Haematology Centre
Blacktown, New South Wales, NSW 2148, Australia
-
Cancer Hospital Chinese Academy of Medical Sciences
Beijing, Beijing Municipality, 100021, China
-
Cancer Research South Australia
Adelaide, South Australia, SA 5000, Australia
-
Columbia University Irving Medical Center
New York, New York, 10032-3725, United States
-
Guangdong Provincial Peoples Hospital Huifu Branch
Guangzhou, Guangdong, 510120, China
-
Guangxi Medical University Cancer Hospital
Nanning, Guangxi, 530021, China
-
Jiangsu Province Hospital
Nanjing, Jiangsu, 210029, China
-
Linear Clinical Research
Nedlands, Western Australia, WA 6009, Australia
-
Next Virginia
Fairfax, Virginia, 22031, United States
-
Shanghai Pulmonary Hospital
Shanghai, Shanghai Municipality, 200433, China
-
Sidney Kimmel Comprehensive Cancer At Johns Hopkins
Baltimore, Maryland, 21287, United States
-
St Vincents Hospital
Fitzroy, Victoria, VIC 3065, Australia
-
The First Hospital of China Medical University Hunnan Branch
Shenyang, Liaoning, 110167, China
-
The Fourth Hospital of Hebei Medical University
Shijiazhuang, Hebei, 050011, China
-
Tianjin Medical University Cancer Institute and Hospital
Tianjin, Tianjin Municipality, 300060, China
-
Union Hospital of Tongji Medical College, Huazhong University of Science and Technology
Wuhan, Hubei, 430022, China
-
Washington University School of Medicine
St Louis, Missouri, 63110-1010, United States
-
West China Hospital, Sichuan University
Chengdu, Sichuan, 610041, China
Conditions
Explore the condition pages connected to this study.